D

DaShenLin Pharmaceutical Group Co Ltd
SSE:603233

Watchlist Manager
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Watchlist
Price: 16.23 CNY -3.22%
Market Cap: 18.4B CNY
Have any thoughts about
DaShenLin Pharmaceutical Group Co Ltd?
Write Note

Income Statement

Earnings Waterfall
DaShenLin Pharmaceutical Group Co Ltd

Revenue
25.9B CNY
Cost of Revenue
-17B CNY
Gross Profit
8.9B CNY
Operating Expenses
-7.4B CNY
Operating Income
1.5B CNY
Other Expenses
-597.6m CNY
Net Income
906.7m CNY

Income Statement
DaShenLin Pharmaceutical Group Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
6 274
N/A
6 545
+4%
6 824
+4%
6 992
+2%
7 421
+6%
7 718
+4%
8 003
+4%
8 421
+5%
8 859
+5%
9 404
+6%
10 029
+7%
10 601
+6%
11 141
+5%
11 925
+7%
12 829
+8%
13 593
+6%
14 583
+7%
15 280
+5%
15 697
+3%
16 446
+5%
16 759
+2%
17 377
+4%
18 425
+6%
19 222
+4%
21 248
+11%
22 518
+6%
23 519
+4%
24 154
+3%
24 531
+2%
25 336
+3%
25 885
+2%
Gross Profit
Cost of Revenue
(3 755)
(3 970)
(4 131)
(4 192)
(4 443)
(4 636)
(4 764)
(4 999)
(5 176)
(5 581)
(6 003)
(6 398)
(6 752)
(7 334)
(7 949)
(8 408)
(8 993)
(9 405)
(9 641)
(10 223)
(10 385)
(10 710)
(11 411)
(11 884)
(13 226)
(14 243)
(14 926)
(15 387)
(15 795)
(16 503)
(17 016)
Gross Profit
2 519
N/A
2 575
+2%
2 693
+5%
2 800
+4%
2 979
+6%
3 083
+3%
3 239
+5%
3 422
+6%
3 683
+8%
3 823
+4%
4 026
+5%
4 203
+4%
4 389
+4%
4 591
+5%
4 880
+6%
5 185
+6%
5 590
+8%
5 875
+5%
6 056
+3%
6 222
+3%
6 374
+2%
6 667
+5%
7 014
+5%
7 338
+5%
8 022
+9%
8 275
+3%
8 593
+4%
8 767
+2%
8 736
0%
8 834
+1%
8 869
+0%
Operating Income
Operating Expenses
(1 932)
(1 962)
(2 051)
(2 152)
(2 341)
(2 399)
(2 547)
(2 715)
(2 968)
(3 042)
(3 163)
(3 281)
(3 479)
(3 525)
(3 661)
(3 843)
(4 199)
(4 359)
(4 599)
(4 856)
(5 239)
(5 415)
(5 652)
(5 901)
(6 438)
(6 498)
(6 696)
(6 792)
(6 959)
(7 128)
(7 364)
Selling, General & Administrative
(1 797)
(1 955)
(2 045)
(2 147)
(2 170)
(2 388)
(2 535)
(2 705)
(2 741)
(3 048)
(3 167)
(3 287)
(3 211)
(3 562)
(3 694)
(3 881)
(3 930)
(4 414)
(4 654)
(4 916)
(4 902)
(5 433)
(5 708)
(5 926)
(5 956)
(6 443)
(6 619)
(6 729)
(6 474)
(7 091)
(7 323)
Research & Development
0
0
0
0
0
0
0
0
0
0
(1)
(2)
0
(1)
(1)
(1)
(4)
(6)
(10)
(13)
(43)
(51)
(56)
(71)
(72)
(80)
(80)
(75)
(76)
(79)
(86)
Depreciation & Amortization
(116)
0
0
0
(159)
0
0
0
(227)
0
0
0
(273)
0
0
0
(312)
0
0
0
(369)
0
0
0
(430)
0
0
0
(463)
0
0
Other Operating Expenses
(20)
(7)
(6)
(5)
(12)
(11)
(11)
(10)
0
7
5
8
6
38
34
39
48
61
65
74
74
69
112
96
19
25
3
12
54
41
45
Operating Income
586
N/A
613
+5%
642
+5%
648
+1%
637
-2%
684
+7%
693
+1%
707
+2%
715
+1%
781
+9%
862
+10%
923
+7%
910
-1%
1 066
+17%
1 219
+14%
1 342
+10%
1 391
+4%
1 516
+9%
1 457
-4%
1 367
-6%
1 135
-17%
1 252
+10%
1 362
+9%
1 437
+6%
1 584
+10%
1 777
+12%
1 897
+7%
1 974
+4%
1 778
-10%
1 706
-4%
1 504
-12%
Pre-Tax Income
Interest Income Expense
(8)
(27)
(28)
(27)
(3)
(13)
(8)
(10)
4
(13)
(15)
(11)
10
(3)
9
21
64
3
32
(21)
(100)
(183)
(253)
(262)
(182)
(183)
(193)
(187)
(143)
(188)
(196)
Non-Reccuring Items
0
0
0
0
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(2)
(2)
(2)
(1)
(0)
(7)
(3)
(1)
(2)
6
7
6
7
18
18
19
14
(3)
1
(4)
Gain/Loss on Disposition of Assets
0
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
(1)
(2)
2
(0)
1
2
3
5
1
2
3
5
1
1
(3)
(8)
(2)
(1)
(5)
(3)
3
4
13
10
(6)
(12)
(18)
(23)
(4)
2
(2)
Pre-Tax Income
577
N/A
584
+1%
615
+5%
621
+1%
635
+2%
672
+6%
686
+2%
700
+2%
720
+3%
770
+7%
849
+10%
915
+8%
919
+0%
1 062
+16%
1 224
+15%
1 354
+11%
1 446
+7%
1 514
+5%
1 482
-2%
1 340
-10%
1 044
-22%
1 080
+3%
1 128
+4%
1 191
+6%
1 415
+19%
1 600
+13%
1 704
+6%
1 779
+4%
1 628
-9%
1 520
-7%
1 302
-14%
Net Income
Tax Provision
(149)
(153)
(160)
(161)
(160)
(169)
(174)
(182)
(194)
(207)
(229)
(247)
(223)
(264)
(301)
(329)
(363)
(368)
(349)
(309)
(240)
(240)
(267)
(291)
(336)
(380)
(384)
(403)
(397)
(360)
(324)
Income from Continuing Operations
429
431
456
460
475
503
512
518
526
563
620
668
697
798
923
1 026
1 083
1 146
1 134
1 031
804
840
861
901
1 079
1 220
1 320
1 377
1 231
1 160
978
Income to Minority Interest
2
2
2
2
0
2
3
4
6
6
5
6
6
0
(6)
(12)
(21)
(24)
(21)
(18)
(13)
(5)
(1)
(5)
(44)
(72)
(81)
(90)
(64)
(92)
(71)
Net Income (Common)
430
N/A
433
+1%
458
+6%
462
+1%
475
+3%
505
+6%
515
+2%
522
+1%
532
+2%
569
+7%
624
+10%
674
+8%
703
+4%
799
+14%
917
+15%
1 014
+11%
1 062
+5%
1 123
+6%
1 113
-1%
1 013
-9%
791
-22%
835
+6%
860
+3%
896
+4%
1 036
+16%
1 148
+11%
1 239
+8%
1 287
+4%
1 166
-9%
1 068
-8%
907
-15%
EPS (Diluted)
0.64
N/A
0.64
N/A
0.67
+5%
0.61
-9%
0.67
+10%
0.67
N/A
0.7
+4%
0.68
-3%
0.71
+4%
0.77
+8%
0.84
+9%
0.9
+7%
0.87
-3%
1.01
+16%
1.18
+17%
1.3
+10%
1.35
+4%
1.43
+6%
1.16
-19%
0.88
-24%
0.69
-22%
0.87
+26%
0.89
+2%
0.78
-12%
0.91
+17%
1
+10%
1.09
+9%
1.13
+4%
1.03
-9%
0.94
-9%
0.79
-16%

See Also

Discover More